Japan’s Takeda Pharmaceutical has struck a £46bn ($62 billion) deal to acquire Irish rival Shire as part of its strategy to expand its global footprint.
Looking to streamline operations yet remain in the healthcare sector, GE has agreed to sell Veritas Capital a portion of its healthcare business.
A healthcare model from the combined forces of Amazon, JP Morgan and Berkshire Hathaway could catch on.
In a global climate of business optimism, uncertainty over Brexit continues to dampen corporate confidence among senior executives in the UK.
2017 mergers and acquisitions were not only staggering in number, topping 50,000 worldwide, but historic in scale and often game-changing.
Amid growing unease, providers, insurers and others are forming unconventional healthcare mergers, while big hospitals are uniting with their own.
Uniting companies from two different industries, the merger presents a new model of healthcare delivery.
M&A values in healthcare decreased by over 60% in Q3 2017 compared to Q2, but volume remains consistent, led by biotech and pharma.
Life-saving gene therapies are within patients’ grasp, but for most, financially out of reach, creating a quandary for insurers and healthcare executives.